Interleukin-13 and tumor necrosis factor-β differentially regulate the production of cytokines by cultured human endometrial stromal cells

Fertility and Sterility

Volumn 79, Issue 3 SUPPL. 1, 2003, Pages 821-827

  Nasu, Kaei ^a   Fukuda, Junichiro ^a   Sun, Bing ^a   Nishida, Masakazu ^a   Miyakawa, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

CC chemokine; CXC chemokine; Endometrial stromal cell; Interleukin 11; Interleukin 13; Interleukin 6; Leukemia inhibitory factor; Tumor necrosis factor

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ARTICLE; CELL ASSAY; CELL CULTURE; CELL FUNCTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DOSE RESPONSE; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; INCUBATION TIME; LEUKOCYTE; MENSTRUAL CYCLE; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; REGULATORY MECHANISM; STROMA; T LYMPHOCYTE; TH2 CELL; TIME;

EID: 0037374635     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04831-8     Document Type: Article

References (44)

1. Nasu K., Matsui N., Narahara H., Tanaka Y., Takai N., Miyakawa I., et al. MaMi, a human endometrial stromal sarcoma cell line that constitutively produces interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1. Arch Pathol Lab Med. 122:1998;836-841.
2. Nasu K., Matsui N., Narahara H., Tanaka Y., Miyakawa I. Effects of interferon-γ on cytokine production by endometrial stromal cells. Hum Reprod. 13:1998;2598-2601.
3. Cork B.A., Li T.C., Warren M.A., Laird S.M. Interleukin-11 (IL-11) in human endometrium expression throughout the menstrual cycle and the effects of cytokines on endometrial IL-11 production in vitro . J Reprod Immunol. 50:2001;3-17.
4. Arici A., Engin O., Atter E., Olive D.L. Modulation of leukaemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab. 80:1995;1908-1915.
5. Nasu K., Fujisawa K., Arima K., Kai K., Sugano T., Miyakawa I. Expression of growth-regulated oncogene α in human endometrial stromal cells. Mol Hum Reprod. 7:2001;741-746.
6. Arima K., Nasu K., Narahara H., Fujisawa K., Matsui N., Miyakawa I. Effects of lipopolysaccharide and cytokines on production of RANTES by cultured human endometrial stromal cells. Mol Hum Reprod. 6:2000;246-251.
7. Hornung D., Dohrn K., Sotlar K., Greb R.R., Wallwiener D., Kiesel L., et al. Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis. J Clin Endocrinol Metab. 85:2000;2604-2608.
8. Nasu K., Narahara H., Matsui N., Kawano Y., Tanaka Y., Miyakawa I. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol Hum Reprod. 5:1999;548-553.
9. Nasu K., Sugano T., Fujisawa K., Arima K., Narahara H., Miyakawa I. Effects of interleukin-4 on the in vitro production of cytokine by human endometrial stromal cells. Mol Hum Reprod. 7:2001;265-270.
10. Chard T. Cytokines in implantation. Hum Reprod Update. 1:1995;385-396.
11. Tabibzadeh S. Cytokines and the hypothalamic-pituitary-ovarian-endometrial axis. Hum Reprod Update. 9:1994;947-967.
12. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profile of lymphokine activities and secreted proteins. J Immunol. 136:1986;2348-2357.
13. Mosmann T.R., Sad S. The expanding universe of T-cell subsets Th1, Th2 and more . Immunol Today. 17:1996;138-146.
14. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship is successful pregnancy a Th2 phenomenon? Immunol Today. 14:1993;353-356.
15. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today. 18:1997;478-482.
16. Marzi M., Vigano A., Trabbattoni D., Villa M.L., Salvaggio A., Clerici E., et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol. 106:1996;127-133.
17. Matthiesen L., Ekerfelt C., Berg G., Ernerudh J. Increased numbers of circulating interferon-γ- and interleukin-4-secreting cells during normal pregnancy. Am J Reprod Immunol. 39:1998;362-367.
18. Piccinni M.-P., Beloni L., Livi C., Maggi E., Scarselli G., Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature Med. 4:1998;1020-1024.
19. Dudley D.J. Recurrent pregnancy loss and cytokines. Not as simple as it seems. J Am Med Assoc. 273:1995;1958-1959.
20. Vives A., Balasch J., Yagüe J., Quintó L., Ordi J., Vanrell J.A. Type-1 and type-2 cytokines in human decidual tissue and trophoblasts from normal and abnormal pregnancies detected by reverse transcriptase polymerase chain reaction (RT-PCR). Am J Reprod Immunol. 42:1999;361-368.
21. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 362:1993;248-250.
22. McKenzie A.N.J., Culpepper J.A., De Waal Malefyt R., Briere F., Punnonen J., Aversa G., et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocytes and B-cell function. Proc Natl Acad Sci USA. 90:1993;3735-3739.
23. Zurawski G., De Vries J.E. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today. 15:1994;19-26.
24. Brombacher F. The role of interleukin-13 in infectious diseases and allergy. BioEssays. 22:2000;646-656.
25. Zurawski S.M., Vega F. Jr, Huyghe B., Huyghe B., Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:1993;2663-2670.
26. Dealtry G.B., Clark D.E., Sharkey A., Charnock-Jones D.S., Smith S.K. Expression and localization of the Th2-type cytokine interleukin-13 and its receptor in the placenta during human pregnancy. Am J Reprod Immunol. 40:1998;283-290.
27. Williams T.J., Jones C.A., Miles E.A., Warner J.O., Warner J.A. Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J Allergy Clin Immunol. 105:2000;951-959.
28. McLaren J., Dealtry G., Prentice A., Charnock-Jones D.S., Smith S.K. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis. Hum Reprod. 12:1997;1307-1310.
29. Cherwinski H.M., Schumacher J.H., Brown K.D., Mosmann T.R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med. 166:1987;1229-1244.
30. Tartaglia L.A., Goeddel D.V. Two TNF receptors. Immunol Today. 13:1992;151-153.
31. Vince G., Shorter S., Starkey P., Humphreys J., Clover L., Wilkins T., et al. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol. 88:1992;174-180.
32. Phillips T.A., Ni J., Hunt J.S. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta. 22:2001;663-672.
33. De Waal Maefyt R., Figdor C.G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol. 151:1993;6370-6381.
34. Deleuran B., Iversen L., Deleuran M., Yssel H., Kragballe K., Stengaard-Pedersen K., et al. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13. Cytokine. 7:1995;319-324.
35. Seitz M., Loetscher P., Dewald B., Towbin H., Baggiolini M. Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells. Eur J Immunol. 26:1996;2198-2202.
36. 2 production by amnion-derived WISH cells. Am J Reprod Immunol. 40:1998;332-338.
37. Berkman N., John M., Roesems G., Jose P., Barnes P.J., Chung K.F. Interleukin 13 inhibits macrophage inflammatory protein-1- production from human alveolar macrophages and monocytes. Am J Respir Cell Mol Biol. 15:1996;382-389.
38. Kucharzik T., Lugering N., Pauels H.-G., Domschke W., Stoll R. IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol. 111:1998;152-157.
39. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T.J., Galanaud P., et al. Regulation of the production of the RANTES chemokine by endothelial cells. Synergic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J Immunol. 154:1995;1870-1878.
40. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Jasmin C., Canonica G.W., Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol. 10:1998;1421-1433.
41. Jordan N.J., Watson M.L., Williams R.J., Roach A.G., Yoshimura T., Westwick J. Chemokine production by human vascular smooth muscle cells modulation by IL-13 . Br J Pharmacol. 122:1997;749-757.
42. Striz I., Mio T., Adachi Y., Robbins R.A., Romberger D.J., Rennard S.I. IL-4 and IL-13 stimulate human bronchial epithelial cells to release IL-8. Inflammation. 23:1999;545-555.
43. Deckers J.G.M., De Haij S., Van Der Woude F.J., Van Der Kooij S.W., Daha M.R., Van Kooten C. IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol. 9:1998;1187-1193.
44. Kumagai N., Fukuda K., Ishimura Y., Nishida T. Synergistic induction of eotaxin expression in human keratinocytes by TNF-α and IL-4 or IL-13. Invest Ophthalmol Vis Sci. 41:2000;1448-1453.